---
title: "The production timeline for the self-ionizable lipids will also be tied to 科瑞生物's R&D and… — 昂利康 — DecisionGateway"
description: "statement by 昂利康, recorded recently — verbatim quote and source citation."
canonical_url: "https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201"
meta:
  "og:description": "statement by 昂利康, recorded recently — verbatim quote and source citation."
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "The production timeline for the self-ionizable lipids will also be tied to 科瑞生物's R&D and… — 昂利康 — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

statement

# **The production timeline for the self-ionizable lipids will also be tied to 科瑞生物's R&D and production progress.**

A statement by [**昂利康**](https://dgw.tmarket.io/actors/01a1e5e4-6301-768b-9dc5-723154c5f34d). Statements are as reported by the cited publishers — not verified by DecisionGateway.

> *自主可離子化脂質的生產時間也會結合科瑞生物的研發生產進度*

stockintelligencenewsPublished 2026-11-11 [ Read source](https://t.me/stockintelligencenews/5715383)

[**昂利康 dossier **](https://dgw.tmarket.io/actors/01a1e5e4-6301-768b-9dc5-723154c5f34d)

## **Discussion**

## **Related claims**

[**Battery production push faces a reality check.**The Morning Essential · statement](https://dgw.tmarket.io/claims/01a1ca38-f9f2-7df7-a59c-14edb10b7e21) [**Three self-developed products — fiber coating, thermal gel and optical coupling adhesive — have been sent for sample validation.**post text · statement](https://dgw.tmarket.io/claims/01a1e6cb-43f0-7ef7-b8df-002de68e0f5e) [**The cosmetic products production project of Unigroup Navoiy was reviewed.**post author · statement](https://dgw.tmarket.io/claims/01a1e509-f999-70dc-ba1d-b4f89f0acf59) [**The concessionaire decided to launch its own production together with a tire pyrolysis unit.**post author · statement](https://dgw.tmarket.io/claims/01a1e93e-63bb-790d-a4bb-2ad6593d01e2) [**The technology is not ready for full production yet.**BIS · statement](https://dgw.tmarket.io/claims/01a1db59-0b65-7a5d-ab9c-4a20a078293c) [**Engineers intend to direct the freed-up time resources to refining dynamic qualities and controlling the reliability of real samples, which will enter series production starting in 2028.**Subaru · commitment](https://dgw.tmarket.io/claims/01a1b682-088e-7a36-a14e-5ef6f2333ab4)

## **More claims by 昂利康**

[**Based on current experimental data, the targets of the three pipelines are relatively clear and have a certain probability of becoming drugs.**statement](https://dgw.tmarket.io/claims/01a1e5e4-63bc-7de4-be99-acf7345f0512) [**Under normal circumstances, the process takes about 1 to 1.5 years.**prediction](https://dgw.tmarket.io/claims/01a1e5e4-63aa-7a64-afae-37120f4fa436) [**The overall cycle is heavily influenced by the technical route and experimental results.**statement](https://dgw.tmarket.io/claims/01a1e5e4-6396-7fa5-8d4d-8d06cfd7bcd8) [**Going from PCC to IND requires completing candidate molecule confirmation, pharmaceutical and non-clinical research work.**statement](https://dgw.tmarket.io/claims/01a1e5e4-6351-7c14-8459-e9fe818b447f) [**Three pipelines are currently at the preclinical PCC stage and are progressing as planned.**statement](https://dgw.tmarket.io/claims/01a1e5e4-633e-79a8-af50-0f103ce4bd57)

[All claims by 昂利康](https://dgw.tmarket.io/claims?claimant_id=01a1e5e4-6301-768b-9dc5-723154c5f34d)

[All claims](https://dgw.tmarket.io/claims)

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts — every claim cited to its public source. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201#webpage","@type":"WebPage","description":"statement by 昂利康, recorded recently — verbatim quote and source citation.","name":"The production timeline for the self-ionizable lipids will also be tied to 科瑞生物's R&D and… — 昂利康 — DecisionGateway","url":"https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201","breadcrumb":{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Claims","item":"https://dgw.tmarket.io/claims","position":2},{"@type":"ListItem","name":"The production timeline for the self-ionizable lipids will…","position":3}]},{"@id":"https://dgw.tmarket.io/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201#/schema/quotation/1","@type":"Quotation","dateCreated":"2026-11-11","isBasedOn":"https://t.me/stockintelligencenews/5715383","text":"自主可離子化脂質的生產時間也會結合科瑞生物的研發生產進度","url":"/claims/01a1e5e4-636f-7f98-8c20-fec0fba6d201","spokenByCharacter":{"@type":"Person","name":"昂利康","@id":"/actors/01a1e5e4-6301-768b-9dc5-723154c5f34d"}}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.
